Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 300 of 885 entries
View as:

A Study to Assess the Effects of 2 Different Prothrombin Complex Concentrates on the Pharmacodynamics of Rivaroxaban in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01656330 Org: User:
Start: 07/31/12 End: 08/31/12 Due: 08/31/13

A Phase II Study of Bermekimab (MABp1) in Patients With Moderate to Severe Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT03496974 Org: User:
Start: 05/21/18 End: 12/11/18 Due: 12/11/19

Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02877134 Org: User:
Start: 08/25/16 End: 01/24/22 Due: 01/24/23

Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib

Phase: N/A Priority: Normal
NCT ID: NCT06120140 Org: User:
Start: 02/16/24 End: 03/31/26 Due: 03/31/27

A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression

Phase: N/A Priority: Normal
NCT ID: NCT02497287 Org: User:
Start: 09/30/15 End: 10/28/17 Due: 10/28/18

A Study to Evaluate the Safety and Clinical Response of Subretinal Administration of CNTO 2476 in Participants With Geographic Atrophy

Phase: N/A Priority: Normal
NCT ID: NCT02659098 Org: User:
Start: 12/04/15 End: 06/05/19 Due: 06/05/20

A Study to Evaluate the Effects of Esketamine on Cardiac Repolarization in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT02737605 Org: User:
Start: 07/01/16 End: 02/23/17 Due: 02/23/18

A Study to Evaluate the Efficacy and Safety of Ibrutinib, in Patients With Mantle Cell Lymphoma Who Progress After Bortezomib Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01599949 Org: User:
Start: 08/31/12 End: 05/31/15 Due: 05/31/16

A Study in Healthy Volunteers to Assess the Effect of Different Types of Food on a Single-dose of JNJ-64417184 Administered as Tablets

Phase: N/A Priority: Normal
NCT ID: NCT04121052 Org: User:
Start: 10/08/19 End: 12/23/19 Due: 12/23/20

Safety and Efficacy of EVT 101 in Treatment-Resistant Depression

Phase: N/A Priority: Normal
NCT ID: NCT01128452 Org: User:
Start: 06/30/10 End: 03/31/11 Due: 03/31/12

Study to Evaluate the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder

Phase: N/A Priority: Normal
NCT ID: NCT02299700 Org: User:
Start: 09/30/14 End: 04/24/15 Due: 04/24/16

Effect of Ketoconazole on the Pharmacokinetics of JNJ-38518168 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01690286 Org: User:
Start: 10/31/12 End: 12/31/12 Due: 12/31/13

A Study to Evaluate the Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT06028438 Org: User:
Start: 08/15/23 End: 10/29/24 Due: 10/29/25

A Study to Assess the Bioequivalence of Fixed Dose Combination (FDC) Tablets of Canagliflozin and Metformin Immediate Release (IR) With Respect to the Individual Components of Canagliflozin and Metformin IR Tablets in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01463228 Org: User:
Start: 09/30/11 End: 01/31/12 Due: 01/31/13

An Observational Study of Infliximab in Participants Suffering From Ankylosing Spondylitis With Hip Involvement

Phase: N/A Priority: Normal
NCT ID: NCT02293681 Org: User:
Start: 04/10/15 End: 05/31/17 Due: 05/31/18

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT06559306 Org: User:
Start: 07/25/24 End: 11/30/27 Due: 11/30/28

A Study to Evaluate the Effect of a Single Dose of CNTO 136 (Sirukumab) on CYP450 Enzyme Activities After Subcutaneous Administration in Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01636557 Org: User:
Start: 10/11/12 End: 10/19/13 Due: 10/19/14

An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT00488631 Org: User:
Start: 09/30/07 End: 02/28/15 Due: 02/28/16

A Study to Explore the Pharmacodynamic Changes When Transitioning From Rivaroxaban to Warfarin in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01400646 Org: User:
Start: 10/31/11 End: 05/31/12 Due: 05/31/13

A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT06785012 Org: User:
Start: 12/26/24 End: 06/26/26 Due: 06/26/27

A Study of Daratumumab

Phase: N/A Priority: Normal
NCT ID: NCT05438043 Org: User:
Start: 12/15/22 End: 01/31/29 Due: 01/31/30

A Study of TAR-200 in Combination With Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Intravesical Bacillus Calmette-Guérin Who Are Ineligible for or Elected Not to Undergo Radical Cystectomy

Phase: N/A Priority: Normal
NCT ID: NCT04640623 Org: User:
Start: 12/18/20 End: 07/02/27 Due: 07/02/28

A Study of JNJ-78278343 in Combination With Either JNJ-63723283 (Cetrelimab), Taxane Chemotherapy, or Androgen Receptor Pathway Inhibitors for Metastatic Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05818683 Org: User:
Start: 04/26/23 End: 09/01/27 Due: 09/01/28

A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

Phase: N/A Priority: Normal
NCT ID: NCT06533098 Org: User:
Start: 02/10/25 End: 12/05/29 Due: 12/05/30

A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT05757869 Org: User:
Start: 04/11/23 End: 05/05/27 Due: 05/05/28